Aldeyra Therapeutics Statistics

Total Valuation

ALDX has a market cap or net worth of $239.58 million. The enterprise value is $165.09 million.

Market Cap	239.58M
Enterprise Value	165.09M

Important Dates

The next estimated earnings date is Thursday, July 31, 2025, before market open.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	n/a

Share Statistics

ALDX has 59.90 million shares outstanding. The number of shares has increased by 0.85% in one year.

Current Share Class	59.90M
Shares Outstanding	59.90M
Shares Change (YoY)	+0.85%
Shares Change (QoQ)	+0.52%
Owned by Insiders (%)	3.13%
Owned by Institutions (%)	39.35%
Float	47.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.78
P/TBV Ratio	3.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.49, with a Debt / Equity ratio of 0.24.

Current Ratio	6.49
Quick Ratio	6.36
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-32.00

Financial Efficiency

Return on equity (ROE) is -65.19% and return on invested capital (ROIC) is -36.71%.

Return on Equity (ROE)	-65.19%
Return on Assets (ROA)	-32.60%
Return on Invested Capital (ROIC)	-36.71%
Return on Capital Employed (ROCE)	-77.49%
Revenue Per Employee	n/a
Profits Per Employee	-$6.41M
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +23.08% in the last 52 weeks. The beta is 0.68, so ALDX's price volatility has been lower than the market average.

Beta (5Y)	0.68
52-Week Price Change	+23.08%
50-Day Moving Average	2.67
200-Day Moving Average	4.60
Relative Strength Index (RSI)	76.64
Average Volume (20 Days)	1,034,081

Short Selling Information

The latest short interest is 4.49 million, so 7.50% of the outstanding shares have been sold short.

Short Interest	4.49M
Short Previous Month	4.71M
Short % of Shares Out	7.50%
Short % of Float	9.43%
Short Ratio (days to cover)	5.58

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-61.15M
Pretax Income	n/a
Net Income	-57.70M
EBITDA	-60.90M
EBIT	-61.15M
Earnings Per Share (EPS)	-$0.97

Full Income Statement

Balance Sheet

The company has $90.06 million in cash and $15.57 million in debt, giving a net cash position of $74.49 million or $1.24 per share.

Cash & Cash Equivalents	90.06M
Total Debt	15.57M
Net Cash	74.49M
Net Cash Per Share	$1.24
Equity (Book Value)	63.60M
Book Value Per Share	1.06
Working Capital	78.44M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-45.71M
Capital Expenditures	n/a
Free Cash Flow	-45.71M
FCF Per Share	-$0.76

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALDX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.85%
Shareholder Yield	-0.85%
Earnings Yield	-24.08%
FCF Yield	-19.08%

Analyst Forecast

The average price target for ALDX is $9.50, which is 137.50% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.50
Price Target Difference	137.50%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1